Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 29,467

Document Document Title
WO/2016/064445A1
Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory dis...  
WO/2016/065264A1
Provided herein are compounds of formula (I) and compositions containing the compounds. The compounds and compositions are useful in the methods of treating, amelioration or prophylaxix of diseases associated with Nrf2/ NF-κΒ pathways....  
WO/2016/058532A1
A method for preparing an isobenzofuran-1(3H)-one compound having the following formula I, wherein R1, R2 and p are as defined in the description.  
WO/2016/059205A1
The present invention relates to a process for the synthesis of 5-hydroxymethyl furfural (HMF) comprising the steps of: 1) dehydrating at least one saccharide selected from monosaccharides having 6 carbon atoms and disaccharides, oligosa...  
WO/2016/057660A8
Provided herein are compounds of formula (I) useful for the treatment of PPAR-delta related diseases (e.g. mitochondrial diseases, muscular diseases, vascular diseases, demyelinating diseases and metabolic diseases).  
WO/2016/057628A1
Methods for providing effective, efficient and convenient ways of producing 2,5-furandicarboxylic acid are presented. In addition, compositions of 2,5-furandicarboxylic acid including 2,5-furandicarboxylic acid and at least one byproduct...  
WO/2016/057660A1
Provided herein are compounds of formula (I) useful for the treatment of PPAR-delta related diseases (e.g. mitochondrial diseases, muscular diseases, vascular diseases, demyelinating diseases and metabolic diseases).  
WO/2016/057322A1
Provided herein are deuterated compounds and compositions useful in increasing PPAR5 activity. The compounds and compositions provided herein are useful for the treatment of PPAR5 related diseases (e.g., muscular diseases, vascular disea...  
WO/2016/057676A1
Methods for providing effective, efficient and convenient ways of producing 2-5-furandicarboxylic acid are presented. In addition, compositions of 2-5-furandicarboxylic acid including 2-5-furandicarboxylic acid, and at toast one byproduc...  
WO/2016/055196A1
The invention relates to a mono-and diester of 2,5-di(hydroxymethyl)-tetrahydrofuran, to methods for the production thereof by esterification in the presence of tertiary amines or in the presence of enzymatic esterfication catalysts and ...  
WO/2016/057687A1
Methods for providing effective, efficient and convenient ways of producing 2,5- furandicarboxylic acid, are presented, in addition, compositions of 2,5-furandicarboxylic acid including 2;5-furandicarboxylic acid and at Least one byprodu...  
WO/2016/056669A1
 Provided is a solid-supported ruthenium complex represented by general formula (1), (2) or (3). Further provided are: a method for manufacturing a reduction product by reducing an organic compound in the presence of the solid-supporte...  
WO/2016/056030A1
The present invention discloses a fast and selective process for the preparation of γ- valerolactone (Gvl) by catalytic hydrogenation of biomass-derived levulinic acid (LA) using recyclable ruthenium (Ru)-based heterogeneous catalysts i...  
WO/2016/057673A1
Methods for providing effective, efficient and convenient ways of producing 2,5- furandicarboxylic acid ate presented. In addition, compositions of 2,5-furandicarboxylic acid including 2,5 -furandicarboxylic acid and at least one byprodu...  
WO/2016/057682A1
Methods for providing effective, efficient and convenient ways of producing 2,5-furandicarboxylic acid are presented. In addition, compositions of 2,5-furandicarboxylic acid including 2,5-furandicarboxylic acid and at least one byproduct...  
WO/2016/055608A1
The present invention relates to a process for producing a water cleavage product, a water cleavage product thus produced, a process for producing at least one water cleavage secondary product, a water cleavage secondary product thus pro...  
WO/2016/049998A1
A fluorescent probe substrate for detecting the activity of human intestine carboxylesterase and uses thereof, which relate to the technical field of pharmaceuticals. The specific probe substrate is an aromatic ester (TCFE for short) of ...  
WO/2016/053938A1
The invention includes compositions comprising NSC59984 or a derivative or analogue thereof and a pharmaceutically acceptable carrier. The invention further includes methods of treating or preventing cancer in a subject, comprising the s...  
WO/2016/053186A1
There is provided a one-pot process for the conversion of sugars to furancarboxylic acids, such as 2,5-furancarboxylic acid (FDCA), in a triphasic system (e.g. water or tetraethylammonium bromide (TEAB) – methyl isobutyl ketone (MIBK) ...  
WO/2016/049774A1
Urea-based and bis-urea based compounds and analogues thereof are disclosed. These compounds are useful in the treatment of androgen-dependent diseases or disorders and androgen receptor-mediated diseases or disorders. Specifically, the ...  
WO/2016/045589A1
Disclosed is a method for preparing chiral γ-secondary amino alcohol. The method is characterized by comprising: adding into a solvent an acid addition salt, an alkali, a metal salt additive and a diphosphine-rhodium complex of β-secon...  
WO/2016/045587A1
Provided is a benzofuran analogue having a structure represented by formula (I) and used as an NS4B inhibitor, or a pharmaceutically acceptable salt of the benzofuran analogue. The benzofuran analogue has anti-hepatitis C virus activity.  
WO/2016/046575A1
A catalyst,method of using, and use of a hydrogenation catalyst, preferably palladium on a support, preferably alumina or activated charcoal support. This in the presence of lithium salts, with salts such as theborates being preferred. T...  
WO/2016/045415A1
A method for asymmetrically catalyzed synthesis of a γ-nitropyrazole amide compound, where a nitroalkene and an α,β-unsaturated pyrazole amide are employed as raw materials, a complex formed by a chiral amine oxide and a rare earth me...  
WO/2016/043589A1
The invention relates to the conversion of renewable biomass resources into valuable compounds. More specifically, it relates to the selective valorisation of 5-(hydroxymethyl)furfural into useful chemicals and fuels. Provided is a metho...  
WO/2016/042772A1
A compound represented by formula (1). (In formula (1), at least one of Ar1 through Ar4 is a group represented by formula (2). (In formula (2), R11 through R18 are each independently a single bond for bonding with the N of formula (1), a...  
WO/2016/041470A1
Provided are compounds of SGLT-2 inhibitors, pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in ...  
WO/2016/040222A1
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein coupled receptor modulato...  
WO/2016/037592A1
Disclosed are an aminosulfonyl compound represented by general formula I or a tautomer, enantiomer, racemate or pharmaceutically acceptable salt thereof, a preparation method therefor, a pharmaceutical composition and a use thereof. The ...  
WO/2016/039510A1
The present invention relates to: an organic compound represented by a combination of chemical formulas 1 and 2; an organic optoelectronic device comprising the organic compound; and a display device.  
WO/2016/038540A1
The present invention relates to fused heterocyclic compound of Formula (I), a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, N-oxide, S-oxide, or a carboxylic...  
WO/2016/039691A1
Compounds of formula (I): wherein R and A- are defined herein as a catalyst for making chiral heterocyclic sulfoxides and a method of producing enantioenriched sulfoxide in the presence of the said compounds.  
WO/2016/038239A1
The invention relates to a group of compounds, having a benzoate ester core, which can modulate the potassium channels of the KCa2/3 family, and are therefore suitable for the treatment of diseases or disorders in which these channels ar...  
WO/2016/036910A1
Described herein are salts of 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxyl ]ethyl} -1-benzofuran-2-carboxamide, in particular that of formula (I): (Formula (I)) wherein HA is naphthalene-1,5-disulfonic acid, naphthalene-2...  
WO/2016/034963A1
Compounds of the formula (I) (I), wherein X is O, S, a direct bond or CR16R17; Y is O or S; R1, R2, R3, R4, R5, R6, R7 and R8 for example are hydrogen, halogen, C1-C4alkyl, or a group of formula (II) or (III) (II) (III) provided that eit...  
WO/2016/035009A1
The present invention relates to a process for preparing an ester having formula R-COO-R' (I), wherein R represents a group selected from: (i) a linear or branched alkyl, containing from 1 to 20 carbon atoms, (ii) an aryl containing from...  
WO/2016/035640A1
The purpose of the present invention is to provide an organic semiconductor film-forming composition which exhibits excellent storage stability and exhibits excellent driving stability, in air, with respect to an obtained organic semicon...  
WO/2016/033348A1
Provided herein are (phenylene)dialkanamines, and methods of producing such (phenylene)dialkanamines from various furanyl and benzyl compounds. Such furanyl compounds may include, for example, bis(nitroalkyl)furans, bis(aminoalkyl)furans...  
WO/2016/030510A1
The present invention relates to heteroaromatic chalcone derivatives, particularly the compounds of formula (I) as described and defined herein, pharmaceutical compositions comprising these compounds, and their medical use, including the...  
WO/2016/029136A1
Disclosed are novel benzamide compounds and the uses thereof for treating diseases and disorders in a patient in need thereof by increasing cellular levels of A3G and/or other members of the A3 family of proteins in the patient. The disc...  
WO/2016/027938A1
The present invention relates to an organic optoelectronic element and a display device comprising the organic optoelectronic element, wherein the organic optoelectronic element comprises: positive and negative electrodes facing each oth...  
WO/2016/028488A1
A process is described for converting hydroxymethylfurfural to furanic products inclusive of 2,5-furandicarboxylic acid, comprising combining a quantity of hydroxymethylfurfural with water to provide an aqueous solution containing at lea...  
WO/2016/028851A1
Amphipathic amine-esters derived from anhydropentitols are prepared through a short sequence of synthetic steps. The process is initiated by the esterification of an anhydropentitol with a fatty acid chloride or a lipase enzyme to form a...  
WO/2016/027005A1
A compound of Formula (I) wherein, X represents an alkyl, alkylene, alkenyl, alkenylene, alkynyl or alkynylene group, optionally having at least one substitutent selected from the group of -OR1 and -NR1R2, or Y represents -OTBS, -OR1, -N...  
WO/2016/028845A1
The present disclosure is directed to methods of making non-ionic, amphiphilic surfactants from 5-hydroxymethyl-2-furfural, furan-2,5-dimethanol and bis-2,5-dihydroxymethyltetrahydrofurans and the novel compounds that are made from those...  
WO/2016/028854A1
Amphipathic amine-esters derived from anhydropentitols are prepared through a short sequence of synthetic steps. The process is initiated by the esterification of an anhydropentitol with a fatty acid chloride or a lipase enzyme to form a...  
WO/2016/024792A1
Provided are a long-lasting, highly efficient organic electroluminescent element material and an organic electroluminescent element using said material. This material for an organic electroluminescent element is a monoamine compound repr...  
WO/2016/025678A1
Furfural is produced from biomass material containing pentosan, in high yields, in a production process comprising treating the biomass with a solution containing at least one α-hydroxysulfonic acid thereby hydrolyzing the biomass to pr...  
WO/2016/025679A1
Methods and processes for the production of valuable organic products and alcohols from biomass material using a closed-loop process having numerous advantages over prior production methods are described. In the process, the biomass is s...  
WO/2016/025677A1
The present invention provides a process for preparing furfural and furfural derivatives using a furfural-derived solvent.  

Matches 51 - 100 out of 29,467